2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide

C49H64N10O16S3 — CID 161454083

IUPAC2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide
SMILESCC[C@H](C)[C@@H]1NC(=O)CNC(=O)[C@@H]2CC(=O)[C@H]([C@@H](C)[C@@H](O)CO)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](CC(N)=O)CC(=O)[C@H](CS(=O)c3[nH]c4cc(OCCCSSc5ccc([N+](=O)[O-])cn5)ccc4c3C2)NC(=O)CNC1=O
InChIInChI=1S/C49H64N10O16S3/c1-4-24(2)43-47(70)53-19-40(66)54-34-23-78(74)48-32(31-8-7-30(17-33(31)55-48)75-10-5-11-76-77-42-9-6-28(18-51-42)59(72)73)12-26(45(68)52-20-41(67)56-43)13-37(63)44(25(3)38(64)22-60)57-46(69)35-16-29(61)21-58(35)49(71)27(14-36(34)62)15-39(50)65/h6-9,17-18,24-27,29,34-35,38,43-44,55,60-61,64H,4-5,10-16,19-23H2,1-3H3,(H2,50,65)(H,52,68)(H,53,70)(H,54,66)(H,56,67)(H,57,69)/t24-,25-,26-,27-,29+,34-,35-,38-,43-,44-,78?/m0/s1
InChIKeyIHTZRWCSILDSSS-JTYNYXQTSA-N
MW1145.31 g/mol
LogP-0.93
Rot. Bonds15

About 2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide

2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide (PubChem CID 161454083) has the molecular formula C49H64N10O16S3 and a molecular weight of 1145.31 g/mol. Its IUPAC name is 2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide.

Molecular Properties

Compound Name2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide
PubChem CID161454083
Molecular FormulaC49H64N10O16S3
Molecular Weight1145.31 g/mol
Exact Mass1144.37
IUPAC Name2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide
SMILESCC[C@H](C)[C@@H]1NC(=O)CNC(=O)[C@@H]2CC(=O)[C@H]([C@@H](C)[C@@H](O)CO)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](CC(N)=O)CC(=O)[C@H](CS(=O)c3[nH]c4cc(OCCCSSc5ccc([N+](=O)[O-])cn5)ccc4c3C2)NC(=O)CNC1=O
InChIInChI=1S/C49H64N10O16S3/c1-4-24(2)43-47(70)53-19-40(66)54-34-23-78(74)48-32(31-8-7-30(17-33(31)55-48)75-10-5-11-76-77-42-9-6-28(18-51-42)59(72)73)12-26(45(68)52-20-41(67)56-43)13-37(63)44(25(3)38(64)22-60)57-46(69)35-16-29(61)21-58(35)49(71)27(14-36(34)62)15-39(50)65/h6-9,17-18,24-27,29,34-35,38,43-44,55,60-61,64H,4-5,10-16,19-23H2,1-3H3,(H2,50,65)(H,52,68)(H,53,70)(H,54,66)(H,56,67)(H,57,69)/t24-,25-,26-,27-,29+,34-,35-,38-,43-,44-,78?/m0/s1
InChIKeyIHTZRWCSILDSSS-JTYNYXQTSA-N
XLogP-0.93
TPSA401.85 Ų
H-Bond Donors10
H-Bond Acceptors19
Rotatable Bonds15
Heavy Atoms78
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001145.31
LogP ≤ 5-0.93
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'disulphide', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide?
The IUPAC name of 2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide (CID 161454083) is 2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide.
What is the SMILES notation for 2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide?
The canonical SMILES for 2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide is CC[C@H](C)[C@@H]1NC(=O)CNC(=O)[C@@H]2CC(=O)[C@H]([C@@H](C)[C@@H](O)CO)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](CC(N)=O)CC(=O)[C@H](CS(=O)c3[nH]c4cc(OCCCSSc5ccc([N+](=O)[O-])cn5)ccc4c3C2)NC(=O)CNC1=O.
What is the InChIKey of 2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide?
The InChIKey is IHTZRWCSILDSSS-JTYNYXQTSA-N. The full InChI is InChI=1S/C49H64N10O16S3/c1-4-24(2)43-47(70)53-19-40(66)54-34-23-78(74)48-32(31-8-7-30(17-33(31)55-48)75-10-5-11-76-77-42-9-6-28(18-51-42)59(72)73)12-26(45(68)52-20-41(67)56-43)13-37(63)44(25(3)38(64)22-60)57-46(69)35-16-29(61)21-58(35)49(71)27(14-36(34)62)15-39(50)65/h6-9,17-18,24-27,29,34-35,38,43-44,55,60-61,64H,4-5,10-16,19-23H2,1-3H3,(H2,50,65)(H,52,68)(H,53,70)(H,54,66)(H,56,67)(H,57,69)/t24-,25-,26-,27-,29+,34-,35-,38-,43-,44-,78?/m0/s1.
What are the key properties of 2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide?
2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide has a molecular weight of 1145.31 g/mol, XLogP of -0.93, 15 rotatable bonds, 10 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-[3-[(5-nitro-2-pyridinyl)disulfanyl]propoxy]-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-6,12,25,29,32,35,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide is sourced from PubChem (CID 161454083), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).